Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001641172-25-009161
Filing Date
2025-05-08
Accepted
2025-05-08 07:39:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7914
  Complete submission text file 0001641172-25-009161.txt   9436
Mailing Address 101 EAST 52ND ST NEW YORK NY 10022
Business Address
HIRSCHMAN ORIN (Filed by) CIK: 0001131362 (see all company filings)

Type: SCHEDULE 13G

Mailing Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003 972 723942377
BiomX Inc. (Subject) CIK: 0001739174 (see all company filings)

EIN.: 823364020 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90744 | Film No.: 25923930
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)